An interview with Opus CEO Dr. Ben Yerxa on founding the company and the Opus mission. » Full Story

Foundation Fighting Blindness Host Ben Shaberman talks with Ash Jayagopal, chief scientific officer at Opus Genetics. » Full Story

Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed financing round led by the venture capital arm of the Foundation Fighting Blindness, the RD Fund. » Full Story